Fuyao Glass Industry Group (03606) issues RMB 650 million ultra-short-term financing bonds.
Fuyao Glass (03606) announced that on September 15, 2026, the company publicly issued its fourth ultra-short-term financing bond of 2026 (abbreviated as "26 Fuyao Glass SCP004") in the national interbank market. The ultra-short-term financing bond code is 012682266, with a total issue amount of RMB 650 million. The term of this ultra-short-term financing bond is 268 days, the issue price is RMB 100 (per RMB 100 face value), and the issue interest rate is 1.44% (annual interest rate). The lead underwriter and bookrunner is Industrial Bank Co., Ltd., and the joint lead underwriter is China CITIC Bank Corporation Limited. The value date is September 16, 2026, and the repayment method is a one-time repayment of principal and interest at maturity.
Fuyao Glass Industry Group (03606) announced that on September 15, 2026, the company publicly issued its fourth ultra-short-term financing bond of 2026 in the national interbank market (abbreviated as "26Fuyao Glass Industry GroupSCP004"), with the ultra-short-term financing bond code 012682266, a total issue amount of RMB 650 million, a term of 268 days for this ultra-short-term financing bond, an issue price of RMB 100 (per RMB 100 par value), and an issue interest rate of 1.44% (annual interest rate). The lead underwriter and bookrunner is Industrial Bank Co., Ltd., and the joint lead underwriter is CITIC BANK Co., Ltd. The value date is September 16, 2026, and the repayment method is a one-time repayment of principal and interest at maturity. The proceeds from this issuance are mainly used to repay financial institution borrowings of the company and its subsidiaries.
Related Articles

CHAOJU EYE CARE (02219) repurchased 40,500 shares for approximately HK$99,100 on September 17.
Jiangsu Cowin Biotech (688426.SH) granted 3.1 million restricted shares to 122 incentive recipients.

ZYLOXTB (02190) repurchased 55,500 shares for HK$1.149 million on September 17.
CHAOJU EYE CARE (02219) repurchased 40,500 shares for approximately HK$99,100 on September 17.

Jiangsu Cowin Biotech (688426.SH) granted 3.1 million restricted shares to 122 incentive recipients.
ZYLOXTB (02190) repurchased 55,500 shares for HK$1.149 million on September 17.

RECOMMEND





